Treatment of virus-induced acute respiratory distress syndrome
The invention is directed to a method of treating viral-induced acute respiratory distress syndrome (ARDS) by administering to a subject with the virial induced ARDS multipotent adult progenitor cells (MAPCs), which are non-embryonic stem, non-germ cells that have a broad differentiation potential a...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
15.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention is directed to a method of treating viral-induced acute respiratory distress syndrome (ARDS) by administering to a subject with the virial induced ARDS multipotent adult progenitor cells (MAPCs), which are non-embryonic stem, non-germ cells that have a broad differentiation potential and extended replication capacity. The virus inducing the ARDS can be a |
---|---|
Bibliography: | Application Number: AU20210261032 |